Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.13B | 11.06B | 10.29B | 8.39B | 7.60B | 7.16B |
Gross Profit | 11.19B | 11.06B | 33.67B | 8.39B | 7.60B | 7.16B |
EBITDA | 3.06B | 0.00 | 0.00 | 3.57B | 3.29B | 1.72B |
Net Income | 3.16B | 3.13B | 3.00B | 2.17B | 1.92B | 783.10M |
Balance Sheet | ||||||
Total Assets | 361.07B | 353.74B | 337.15B | 323.87B | 307.43B | 277.39B |
Cash, Cash Equivalents and Short-Term Investments | 41.68B | 25.13B | 31.51B | 35.68B | 61.92B | 52.60B |
Total Debt | 55.52B | 42.01B | 69.75B | 36.57B | 32.72B | 31.24B |
Total Liabilities | 328.47B | 322.97B | 308.65B | 298.56B | 32.72B | 31.24B |
Stockholders Equity | 24.65B | 23.14B | 21.65B | 19.35B | 18.00B | 17.34B |
Cash Flow | ||||||
Free Cash Flow | 2.62B | -9.78B | 2.06B | -9.29B | 10.86B | 23.94B |
Operating Cash Flow | 3.40B | -9.03B | 2.59B | -8.82B | 11.40B | 24.49B |
Investing Cash Flow | -981.00M | -850.00M | -599.00M | -233.10M | -483.40M | -351.60M |
Financing Cash Flow | -938.00M | -1.55B | 2.66B | 8.12B | -1.31B | 1.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $27.59B | 12.87 | 11.58% | 3.59% | 2.08% | 2.87% | |
77 Outperform | $22.25B | 11.62 | 11.59% | 4.06% | 2.83% | 20.85% | |
77 Outperform | $38.85B | 11.61 | 14.71% | 3.41% | 9.59% | 17.05% | |
77 Outperform | $29.39B | 12.18 | 9.47% | 2.94% | 0.62% | 14.75% | |
75 Outperform | $24.50B | 10.99 | 10.70% | 0.41% | -2.10% | -6.84% | |
73 Outperform | $23.75B | 12.06 | 10.43% | 3.91% | 5.28% | 28.03% | |
67 Neutral | $17.02B | 11.60 | 9.79% | 3.95% | 10.61% | 2.06% |